CONTEXT: Despite the absence of progesterone receptor protein in human endometrial endothelial cells (HEECs), endometria of women receiving long-acting progestin-only contraceptives (LAPCs) display reduced uterine blood flow, elevated reactive oxygen species generation, increased angiogenesis, and irregularly distributed, enlarged, fragile microvessels resulting in abnormal uterine bleeding. OBJECTIVE: We propose that paracrine factors from LAPC-treated human endometrial stromal cells (HESCs) impair HEEC functions by shifting the balance between HEEC viability and death in favor of the latter. DESIGN AND SETTING: Proliferation, apoptosis, and transcriptome analyses were performed in HEECs treated with conditioned medium supernatant (CMS) derived from HESCs treated with estradiol (E2) ± medroxyprogesterone acetate or etonogestrel under normoxia or hypoxia. Mass spectrometry interrogated the CMS secretome while immunostaining for neuronal pentraxin-1 (NPTX1), cleaved caspase-3, and cytochrome c was performed in cultured HEECs and paired endometria from women using LAPCs. MAIN OUTCOME: HEEC apoptosis and its underlying mechanism. RESULTS: HESC CMS from E2 + medroxyprogesterone acetate or E2 + etonogestrel incubations under hypoxia induced HEEC apoptosis (P < .05), whereas mass spectrometry of the CMS revealed increased NPTX1 secretion (P < .05). Endothelial cleaved caspase-3 and stromal NPTX1 immunoreactivity were significantly higher in LAPC-treated endometria (P < .001). Transcriptomics revealed AKT signaling inhibition and mitochondrial dysfunction in HEECs incubated with HESC CMS. In vitro analyses proved that CMS decreased HEEC AKT phosphorylation (P < .05) and that recombinant NPTX1 (P < .05) or NPTX1 + H2O2 (P < .001) increase HEEC apoptosis and cytosolic cytochrome c levels. CONCLUSIONS: LAPC-enhanced NPTX1 secretion and reactive oxygen species generation in HESCs impair HEEC survival resulting in a loss in vascular integrity, demonstrating a novel paracrine mechanism to explain LAPC-induced abnormal uterine bleeding.
CONTEXT: Despite the absence of progesterone receptor protein in human endometrial endothelial cells (HEECs), endometria of women receiving long-acting progestin-only contraceptives (LAPCs) display reduced uterine blood flow, elevated reactive oxygen species generation, increased angiogenesis, and irregularly distributed, enlarged, fragile microvessels resulting in abnormal uterine bleeding. OBJECTIVE: We propose that paracrine factors from LAPC-treated human endometrial stromal cells (HESCs) impair HEEC functions by shifting the balance between HEEC viability and death in favor of the latter. DESIGN AND SETTING: Proliferation, apoptosis, and transcriptome analyses were performed in HEECs treated with conditioned medium supernatant (CMS) derived from HESCs treated with estradiol (E2) ± medroxyprogesterone acetate or etonogestrel under normoxia or hypoxia. Mass spectrometry interrogated the CMS secretome while immunostaining for neuronal pentraxin-1 (NPTX1), cleaved caspase-3, and cytochrome c was performed in cultured HEECs and paired endometria from women using LAPCs. MAIN OUTCOME: HEEC apoptosis and its underlying mechanism. RESULTS: HESC CMS from E2 + medroxyprogesterone acetate or E2 + etonogestrel incubations under hypoxia induced HEEC apoptosis (P < .05), whereas mass spectrometry of the CMS revealed increased NPTX1 secretion (P < .05). Endothelial cleaved caspase-3 and stromal NPTX1 immunoreactivity were significantly higher in LAPC-treated endometria (P < .001). Transcriptomics revealed AKT signaling inhibition and mitochondrial dysfunction in HEECs incubated with HESC CMS. In vitro analyses proved that CMS decreased HEEC AKT phosphorylation (P < .05) and that recombinant NPTX1 (P < .05) or NPTX1 + H2O2 (P < .001) increase HEEC apoptosis and cytosolic cytochrome c levels. CONCLUSIONS:LAPC-enhanced NPTX1 secretion and reactive oxygen species generation in HESCs impair HEEC survival resulting in a loss in vascular integrity, demonstrating a novel paracrine mechanism to explain LAPC-induced abnormal uterine bleeding.
Authors: C J Lockwood; Y Nemerson; S Guller; G Krikun; M Alvarez; V Hausknecht; E Gurpide; F Schatz Journal: J Clin Endocrinol Metab Date: 1993-01 Impact factor: 5.958
Authors: Chary López-Pedrera; Nuria Barbarroja; Paula Buendía; Antonio Torres; Gabriel Dorado; Francisco Velasco Journal: Haematologica Date: 2004-03 Impact factor: 9.941
Authors: Kyle D Mansfield; Robert D Guzy; Yi Pan; Regina M Young; Timothy P Cash; Paul T Schumacker; M Celeste Simon Journal: Cell Metab Date: 2005-06 Impact factor: 27.287
Authors: Umit A Kayisli; Murat Basar; Ozlem Guzeloglu-Kayisli; Nihan Semerci; Helen C Atkinson; John Shapiro; Taryn Summerfield; S Joseph Huang; Katja Prelle; Frederick Schatz; Charles J Lockwood Journal: Proc Natl Acad Sci U S A Date: 2015-04-06 Impact factor: 11.205
Authors: Asli Ozmen; Ozlem Guzeloglu-Kayisli; Selcuk Tabak; Xiaofang Guo; Nihan Semerci; Chinedu Nwabuobi; Kellie Larsen; Ali Wells; Asli Uyar; Sefa Arlier; Ishani Wickramage; Hasan Alhasan; Hana Totary-Jain; Frederick Schatz; Anthony O Odibo; Charles J Lockwood; Umit A Kayisli Journal: Front Cell Dev Biol Date: 2022-06-28
Authors: Ozlem Guzeloglu Kayisli; Umit A Kayisli; Murat Basar; Nihan Semerci; Frederick Schatz; Charles J Lockwood Journal: PLoS One Date: 2015-10-05 Impact factor: 3.240
Authors: Jack E Teasdale; Andrew C Newby; Nicholas J Timpson; Marcus R Munafò; Stephen J White Journal: Drug Alcohol Depend Date: 2016-04-22 Impact factor: 4.492